LINC00973 and lung cancer: As we all know, gefitinib and erlotinib were common anti-cancer drugs for lung cancer (26, 27), and Gefitinib and erlotinib could reduce the expression of carcinogenic LINC00973, which was expected to improve the prognosis of lung cancer patients.